FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression - Benzinga

Submitted by Anonymous (not verified) on Tue, 01/21/2025 - 16:57

FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression  Benzinga